Auger Emitting 161 Tb-PSMA-617 Radioligand Therapy for Prostate Cancer | Saarland University Hospital

Deep within the specialized corridors of the Saarland University Hospital in Homburg, the nuclear medicine department is rewriting the playbook for advanced prostate cancer treatment. While much of the world has recently caught up to the benefits of Lutetium-177, our team in Homburg is already looking past the horizon, pioneering the use of Terbium-161 (161Tb)-PSMA-617. This isn’t just a marginal improvement; it represents a fundamental shift in how we approach metastatic disease. By choosing this facility, patients enter an environment where the transition from theoretical research to life-saving clinical application occurs faster than almost anywhere else in Europe. We have designed this program for those whose journey has led them to the limits of standard care, offering a sophisticated biological weapon that targets cancer where it is most vulnerable. The true distinction of our Terbium-161 program lies in its unprecedented ability to deliver energy at the sub-cellular level. Conventional therapies often struggle with micrometastases, tiny clusters of cancer cells too small for traditional radiation to effectively target. Terbium-161 changes this dynamic by emitting a unique combination of beta particles and high-energy Auger electrons. These Auger electrons act like a molecular scalpel, traveling only a few micrometers to deposit a massive, lethal dose of radiation directly into the DNA of the cancer cell. This means we can achieve a higher kill rate for microscopic disease while significantly sparing the surrounding healthy organs, such as the salivary glands and kidneys, which are often the primary victims of less precise isotopes. Undergoing radioligand therapy at Saarland University Hospital is an experience defined by extreme scientific rigor and high-touch clinical monitoring. The process is anchored by our world-class dosimetry protocols, which enable our medical physicists to map the isotope's movement through your body with pinpoint accuracy. Unlike standard fixed-dose centers, our Homburg specialists adjust treatment based on real-time biological feedback, ensuring the radiation is concentrated exactly where PSMA-positive receptors are most active. Throughout your stay in our modern, specialized therapy ward, you are supported by a nursing and medical team that has managed more PSMA-directed cycles than nearly any other team globally, providing a level of safety and technical intuition that only comes with being a high-volume center of excellence.